A viral nanoparticle with dual function as an anthrax antitoxin and vaccine.

PLoS Pathog · 2007 · PMC2000967 · PMID 17922572

Europe PMC DOI

hedged sentence

0.0046

closest p · 0.1× alpha

0.0046

boldest claim

The sentences

highly significantp = 0.0046actually significant

The delay was notably longer for chimera 264 (89 min) than sANTXR2 (77 min), and the difference was highly significant ( p = 0.0046), suggesting increased therapeutic potency of the multivalent particles over monomeric sANTXR2 as an inhibitor of the anthrax toxin.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.